Le Lézard
Classified in: Health
Subjects: PDT, TDS, FVT

The #1 Cannabis Beverage in Washington State Just Got Stronger



SEATTLE, Nov. 10, 2017 /PRNewswire/ -- Tarukino, Inc. is introducing new versions of the best selling cannabis infused beverage in Washington state. Happy Apple has been available to the market in 10 MG bottles but now, you can get Happy Apple in both 50 MG and 100 MG bottles in the state of Washington.

Introducing Happy Apple 50 MG

Made with the same ingredients as the 10 MG Happy Apple, an already delicious and crisp, cannabis-infused beverage with no bad weed taste or odor, the gluten-free Happy Apple 50 MG and 100 MG options are made with homegrown, world-famous Washington apples.

"Happy Apple is the most delicious cannabis beverage on the market," says Marketing Director, Jason Lander, "and we couldn't be more excited to give our customers what they've asked for by introducing these 50 and 100 MG bottles."

Happy Apple is made with Tarukino's proprietary water-based cannabis emulsion called S?rsetm.  Handcrafted in Seattle's SoDo neighborhood,  S?rse allows cannabis infused products to maintain their potency and accuracy when cooked, chilled or frozen, and removes all cannabis taste and smell. It's the perfect, smoke-free happy hour option.

Visit Tarukino and learn more about Happy Apple and the other new cannabis-infused products soon to hit the market from Tarukino at the MJBizCon convention in Las Vegas, November 14th - 17th, 2017.

Visit our website to find a Happy Apple retailer near you and see for yourself why Happy Apple is the #1 best selling cannabis infused beverage in the state of Washington.
www.happyapple.com

Tarukino, Inc. is a technology driven group of innovators creating surprisingly delightful, cannabis infused products for those in search of something better. Based in Seattle, Washington, Tarukino produces cannabis products based on its core technology, S?rsetm. S?rse is the first and only water soluble cannabis product that produces entirely taste- and odor-free cannabis emulsions for infusion of medical and recreational products.

 

SOURCE Tarukino, Inc.


These press releases may also interest you

at 12:16
HealthCombix today announced that it has partnered with San Francisco based NuCypher to explore distributed security technology integrations to solve privacy, consent, and identity challenges in healthcare around the globe. HealthCombix, a...

17 fév 2018
The next frontier is truly the mind. To explore our vast galaxy, one of the most useful avenues has been Virtual Reality (VR). What makes VR so special is its ability to allow you to transport into another world without literally having to move an...

17 fév 2018
AbbVie , a global research and development-based biopharmaceutical company, today presented new positive results from the pivotal Phase 3 ultIMMa-1 and ultIMMa-2 replicate clinical trials that evaluated the safety and efficacy of risankizumab (150...

17 fév 2018
AbbVie , a global research and development-based biopharmaceutical company, today presented new positive results from a Phase 2b dose-ranging study evaluating upadacitinib, an investigational, once-daily oral JAK1-selective inhibitor, in adult...

17 fév 2018
Evolus, Inc. today announced the presentation of data from the Phase III comparative clinical trial of its investigational prabotulinumtoxinA 900 kilodalton (kDa) neuromodulator at the American Academy of Dermatology (AAD) meeting....

17 fév 2018
Veterans gathered to bond and learn adaptive winter sports techniques from experienced instructors at the Arizona Snowbowl. During the two-day-adaptive ski and snowboard experience with Wounded Warrior Project® (WWP), some veterans with injuries...




News published on 10 november 2017 at 15:53 and distributed by: